StockWatch
·

SAKSOFT LTD. Q2 FY27 Results

SAKSOFTQ2 FY27 Results
Filing
Result:Weak· Market: Down#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue248.610.0%3.8%
Total Income251.600.5%5.0%
Expenditure209.290.7%2.0%
PBT42.310.6%17.5%
Net Profit32.129.7%10.7%
OPM17.60%0.66pp1.98pp
NPM12.77%1.07pp0.81pp
EPS2.499.2%11.1%
View full financials

IT-sector core metric (constant-currency revenue) fell 3.8% YoY with PAT down 10.7% and operating margin compressing 198bps as BFS/Commerce profits slumped, leaving only the Emerging vertical as an offset and guidance tracking well below management's FY27 target.

SAKSOFT LTD. · Q2 FY27 · THE VERDICT

Flat Quarter, Guidance Under Strain, FY27 Target Increasingly Distant

SAKSOFT delivered a flat quarter (revenue ₹248.6 Cr, down 3.8% YoY) while maintaining an FY27 guidance of ₹1,200 Cr that now requires 40% H2 growth and relies on undisclosed M&A. The gap between guidance and current trajectory is the story.

12 Nov 2026 · 6 min read
Q2 Revenue

₹248.6 Cr

Flat QoQ, -3.8% YoY

Q2 PAT

₹32.1 Cr

+10% QoQ, -10.7% YoY

H1 Revenue

₹497 Cr

-2% YoY

H1 EBITDA margin

17.93%

-107 bps YoY

The core tension: guidance vs. trajectory

SAKSOFT maintained its FY27 revenue guidance of ₹1,200 Cr on the call—a nominal 19% growth from the FY26 base of ₹1,007 Cr. But H1 delivered ₹497 Cr, down 2% YoY. H2 now needs ₹703 Cr—a 40% quarter-on-quarter lift from the H1 average—to land the target. Management acknowledged this is a "tough ask" and tied it to "non-linear options" (M&A, partnerships) that have not been identified, quantified, or announced. The guidance is nominally maintained but increasingly contingent and distant from current momentum.

What's driving the shortfall

Three forces are compressing revenue and margin simultaneously:

  • AI-driven cannibalization: Management claims 30–50% efficiency gains, forcing team right-sizing from 50 to 30 members on product engineering. In the short term, customers reduce spend as automation replaces billable hours.

  • Customer in-sourcing: Multiple customers are moving work to captive centers. Called 'temporary blips' by management but acknowledged as impacting current quarter revenue visibility. Q2 revenue decline reflects this directly.

  • U.S. pipeline stall: The U.S. contributes ~51% of revenue. Pipeline of ~USD 25 million is not converting at expected pace; management attributed it to 'rigor' issues and lack of on-ground presence. New CEO appointment suggests urgency but execution is unproven.

Management claims vs. what the numbers show

50–50% AI efficiency gains; revenue cannibalization short-term.

Supported

Revenue down 3.8% YoY; customer in-sourcing admitted; team being right-sized.

100% of projects are AI; AI is a universal force.

Overstated

When pressed, management clarified: 'no project started because of AI only; every project uses AI in some form.'

USD 500 million target by 2030 is achievable; confident we'll get close.

Contradicted

Requires 39% CAGR from flat base; last 4 quarters flat; no M&A/deal disclosed.

In-sourcing is temporary and won't derail recovery.

Overstated

Customers actively in-sourcing work; impact to current revenue visibility real. No timeline for recovery provided.

FY27 ₹1,200 Cr guidance firm; 50% of Q3 already locked.

Contingent

Contingent on unspecified M&A. H2 requires 40% growth vs. H1. Current trajectory -2% YoY.

What changed on this call

New CEO & restructuring: Gurmeet Chahal (ex-public company CEO) appointed to drive U.S. scaling. Chief Growth Officer hired 3 weeks prior. New CFO and COO (Niraj Kumar) clarifying strategy. Positive signal but early-stage.

Outcome-based model shift: Currently ~10% of revenue; target to reach 29% by FY28. This is a margin-expansion play (higher pricing, stickier contracts) but adds near-term complexity and revenue recognition volatility. Management calls it a pillar of recovery.

Margin guidance deferred: Prior call implied 18%+ EBITDA margin was achievable near-term. Now deferred to 2–3 years due to outcome-based transition and sales/leadership investments. Q2 EBITDA margin 17.6%, down 66 bps QoQ from Q1 17.76%.

How the street is positioned—and what it tells us

Current price

₹134.7

as of 2026-11-11

52-week range

₹107.6–₹223.0

Current +25% off low, -40% off high

All-time high

₹321.75

Current -58.14% from peak

RSI

47.9

Neutral (not oversold)

The drawdown context: SAKSOFT has lost 58% from its all-time high, putting it well below both its 50- and 200-day moving averages (₹140.62 and ₹149.34, respectively). The stock is down 40% from the 52-week high of ₹223, which suggests the market began repricing well ahead of Q2. This is not an oversold washout (RSI 47.9 is neutral)—it reflects a considered repricing of execution risk.

Institutional positioning: FII ownership fell to 2.17% from 2.40% last quarter, a 23-basis-point decline. Notably, in early July—before Q2 results—bulk block deals showed significant institutional selling in the ₹209–₹211 range, well above current price. This suggests institutions were exiting ahead of the print, and the post-result price action has not recovered that selling. The market is not re-bidding the stock materially on results.

Why this matters: The combination of a 58% drawdown, FII trimming, and failed post-result recovery suggests the market is pricing in both near-term execution risk and medium-term uncertainty around guidance credibility. The stock has already undergone a reckoning; the question is whether it has gone too far or not far enough.

Risks, ranked by how much they should concern a holder

What matters most to downside

Customer concentration: top 5 = 40% of revenue; top 10 = 58%.

High

Loss of one major customer is material and limits pricing power. Churn risk in a downturn or if competitor wins a large deal.

FY27 guidance increasingly disconnected from current run-rate.

High

Requires 40% H2 growth, contingent on undefined M&A. Credibility erosion if H2 misses or M&A is not announced. Implies 'surprise' or 'reset' is likely.

AI cannibalization unresolved; team right-sizing ongoing.

High

Revenue headwind persists until outcome-based model gains traction (FY28 target). Management calls it 'short-term' but it's happening now. No clear inflection point.

U.S. pipeline conversion lagging; new CEO execution unproven.

Medium

U.S. is 51% of revenue and strategic growth driver. New leadership is positive but track record on this team is zero. Execution delays risk further miss.

Margin deferred to 2–3 years; near-term compression.

Medium

Outcome-based transition and leadership investments will weigh on margins. Market may not wait 2–3 years for recovery if Q3/Q4 misses or margins deteriorate further.

Macro softness; discretionary IT spend discipline ongoing.

Medium

Clients deferring non-strategic projects. No visibility on when this eases. Impact to pipeline conversion and deal size.

The bull-bear ledger
  • New CEO and CFO are proven public-company operators

  • Outcome-based model is a structural margin lever (target 29% of revenue by FY28)

  • AI-first transformation, if executed, creates defensibility

  • Stock repriced 58% from ATH; some downside already discounted

  • Q2 flat with margin down 66 bps QoQ; near-term momentum negative

  • FY27 guidance (₹1,200 Cr) contingent on undisclosed M&A; highly uncertain

  • H1 revenue -2% YoY; H2 needs 40% growth to hit target

  • AI cannibalization and customer in-sourcing are real; timeline for recovery unclear

  • Top 5 customers = 40% of revenue; concentration risk high

  • U.S. pipeline track record weak; new CEO execution unproven

  • Management tone shifted from bullish to cautious/defensive in Q&A

  • Margin guidance deferred to 2–3 years; near-term pressure

What to watch next

Three things that resolve the debate
  • 1 · Q3 revenue trajectory

    Management claimed '50% of Q3 already locked.' If Q3 comes in below ₹240 Cr (which would maintain a flat QoQ), guidance credibility breaks further. Above ₹260 Cr would signal H2 recovery is real.

  • 2 · M&A or partnership announcement

    FY27 guidance is contingent on undefined M&A. If no deal is announced by Q3 end or Q4 start, guidance will likely be reset. Announcement would de-risk near-term narrative.

  • 3 · Outcome-based model ramp and margin trajectory

    Current outcome-based revenue ~10% of total. Ramp to 15–18% by Q3/Q4 (en route to 29% by FY28) would signal model is gaining traction. If margin stabilizes or improves QoQ, execution is credible. Further compression signals transition headwinds persist.

The number to track

From here, watch Q3 revenue guidance and revised FY27 target. If management raises or reconfirms ₹1,200 Cr with a concrete deal or path (no longer "non-linear options"), the stock has bottoming credibility. If guidance is reset downward or deferred pending M&A, the repricing likely has further to go. Outcome-based revenue % and EBITDA margin trajectory are secondary tells but matter for medium-term recovery.

SAKSOFT delivered a flat Q2 amid deliberate AI-driven revenue trade-offs and customer in-sourcing. The real question is not the quarter—it's whether FY27 guidance of ₹1,200 Cr is a pathway or a placeholder. Requiring 40% H2 growth and undefined M&A, it reads more like the latter.

Management restructuring and outcome-based model shift are credible structural positives. But they are unproven on this team and this timescale. The market has repriced sharply (−58% from ATH), and some downside has already been discounted. But credibility will hinge on whether H2 accelerates or further disappoints, and whether M&A is real or perpetually deferred.

Verdict: Hold. Wait for Q3 and M&A clarity before adding conviction either direction. The stock is no longer a bargain, but it's not yet a compulsory short. Execution in the next 6–8 weeks will tell.

Informational and educational content only. Not investment advice.